Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atractylodes japonica root is a botanical extract derived from the rhizome of *Atractylodes japonica Koidzumi*, a plant used in traditional East Asian medicine. It contains bioactive compounds such as atractylenolides (I and III), atractylone, and polyacetylene derivatives. The extract exhibits anti-inflammatory, antioxidant, and antibacterial properties. Its mechanism of action involves the suppression of inflammatory mediators, specifically by inhibiting the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Historically, it has been used for digestive disorders, fluid retention, and respiratory conditions. While it was previously listed as an approved substance in some jurisdictions, it has since been withdrawn from those specific pharmaceutical registries and is currently found in dietary supplements and cosmetic products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on atractylodes japonica root.